Sunday, 21 May 2017

DRREDDY technical analysis


DRREDY seems to have stabilized on the support line and stock might have upward trend in coming weeks. Accumulating the stock would be good idea as company received USFDA approval for the launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market.